Background: Epidermodysplasia verruciformis (EV) is a genodermatosis leading to infections with cutaneous HPV, persistent plane warts and a high rate of non-melanoma skin cancer (NMSC). Biallelic loss-of-function mutations in TMC6 and TMC8 are known to be causative.
Introduction
Epidermodysplasia verruciformis (EV) (OMIM 226400) is a rare, autosomal recessive genodermatosis with unknown prevalence. EV patients develop plane wart-like lesions during childhood and have a high risk for early onset development of non-melanoma skin cancer (NMSC) on UV light exposed skin. Biallelic loss-of-function (LoF) mutations in either TMC6 or TMC8, also named EVER1 or EVER2, both located on chromosome 17q, are causative for splice products identified in the patients lacked complete exon 9, and a subset additionally lacked exon 10 (Fig. 2f ). The former transcript is predicted to result in a frameshift and premature stop codon after 30 amino acids, while the latter transcript would result in an inframe deletion of 88 amino acids. With the methods described above, infections with β-HPV (type 5 and 9) were detected in all three patients' plane warts.
Discussion
All cases presented in this study showed the typical clinical, histopathological, and viral phenotype of EV. In addition to these characteristic EV features, one individual presented palmar warts, which constitutes a rarely described feature of EV. This patient was affected by diverse NMSCs, including a cSCC on the side of her nose. Since she had never developed plane warts in this region before, a pre-existing lesion does not seem to be a prerequisite for development of NMSC. Reports about the frequency of precanceroses and NMSCs in EV range from none 10 to numerous 11 . Our systematic literature review summarizes cases with congenital EV reported to date, including the novel patients described in this study (table 1) .
Patients were excluded if they had acquired EV (onset after HIV infection or immunosuppression) or had a very atypical phenotype (excessive wart growth). In total, 501 cases belonging to 347 families have been described with slightly more male patients. The actual number of diagnosed individuals is probably even higher since not every case is presumably published. For example, a clinic in Iraq observed 4-6 affected families per year, mostly from two areas, without reporting details 12 , and Japanese clinics reported 66 patients in a questionnaire survey 13 . There are no conclusive studies about the life expectancy of EV patients. However, under regular treatment of precanceroses and NMSCs, patients can reach old age 11 .
Despite the EV-typical appearance of patient 1, we were unable to detect any LoF mutation in TMC6 or TMC8. This was in contrast to the second family (cases 2-4), in whom we detected a splice site mutation in TMC8. Nevertheless, we were able to measure regular amounts of aberrantly spliced TMC8 transcripts, which is consistent with a recent report of regular level of transcripts with in-frame deletions and protein expression in one patient with splice site mutations in TMC8 10 . These findings exclude the mechanism of nonsense mediated decay (NMD) , which has been reported in patients with TMC8 premature stop mutation 3 . In contrast to these cases, our patients have not developed any NMSC so far. Moreover, the other EV patient with splice site mutations and stable aberrant transcripts did not develop NMSC either 10 . These findings suggest that the stable transcript and evading NMSC are potentially correlated, which needs to be proven in further studies and a follow-up of our young patients.
Since 2002, the TMC6 and TMC8 genes have been analysed in 32 families, but in approximately 40% of them (13 families), no LoF mutation could be detected. These findings suggest mutations of at least one more gene connected to EV. Nearly all families with either TMC6 or TMC8 deficiency carry a homozygous private mutation indicating consanguinity, which is reported in about half of all patients.
HPV analyses in samples from 208 patients showed a positive result in all except one case 14 .
HPV type was determined in 180 of these cases (table S1). Beta-HPV was detected in 159 patients, α-HPV in 57 patients, and γ-HPV in one patient (Fig. 3) . Most α-HPVs were detected along with β-HPVs. However, some α-HPV infections were reported without co-infection with β-HPV. These reports should be interpreted with caution. In some studies, the methods used had been developed to find α-HPVs, but were unable to detect β-HPVs. Other studies analysed only perianal samples. In several older studies, HPV-3 was detected by using methods relying on DNA hybridisation or restriction enzyme digestion, without amplification or sequencing. These methods had limited sensitivity and did not differentiate between all types known today. Nevertheless, a recent report has described one individual with a cutaneous HPV-10 (α-HPV) infection without concurrent β-HPV infection, despite a methodical search 16 .
HPV-5 and HPV-8 are often mentioned as the most frequent EV-related HPV types. In contrast to that current opinion, our literature review shows that HPV-14 and HPV-20 have been reported more frequently than HPV-8, which shows the need to pay attention to HPV types other than 5 and 8 in future studies. In addition, EV lesions were shown to be coinfected with β-HPVs and polyomaviruses 17 . We conclude that further investigations on the effect of β- a mutation at the donor splice site of intron 9 (TMC8 c.1127+1G>C), which was found to be homozygous in all three affected siblings and heterozygous in the parents. A wildtype control is shown. (e) Relative expression of exons 1-2 and 9-10 of TMC8 measured by qRT-PCR.
Each symbol represents the average of one individual measured in three replicates. The grey horizontal bars indicate the group average. Whereas no expression could be detected for exon 9-10, a regular expression level is observed for exon 1-2. (f) TMC8 splice products identified in controls and patients. The region covered by sequencing is indicated in black.
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